Table 4 Comparisons of lymphocyte count and CRP on the fifth day of treatment between the DBT and placebo groups.

From: A prospective, randomized, double-blind, placebo-controlled trial of the Kampo formula daiobotanpito combined with antibiotic therapy for acute diverticulitis

  

DBT

(%)

Placebo (%)

P-value

n = 66

n = 62

Lymphocytes

> 16,000/µL increase

28 (42.4)

38 (61.3)

0.033*

CRP level

> 11 mg/dL decrease

15 (20.8)

5 (7.4)

0.023*

  1. CRP: C-reactive protein, DBT: daiobotanpito.
  2. *Statistical significance/P <.05.